Petros Pharmaceuticals Files 2024 Annual Report
Ticker: PTPI · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1815903
| Field | Detail |
|---|---|
| Company | Petros Pharmaceuticals, Inc. (PTPI) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Petros Pharma dropped its 2024 10-K. Full financials and biz details inside.
AI Summary
Petros Pharmaceuticals, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, incorporated in Delaware and headquartered in New York, operates in the pharmaceutical preparations sector. Key financial details and operational aspects for the period are outlined in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Petros Pharmaceuticals' financial performance, strategic initiatives, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Petros faces inherent risks related to drug development, regulatory approvals, market competition, and intellectual property.
Key Numbers
- 10-K — Filing Type (Annual report filed with the SEC)
- 2024-12-31 — Fiscal Year End (Period covered by the report)
Key Players & Entities
- Petros Pharmaceuticals, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- New York (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Petros Pharmaceuticals, Inc.?
Petros Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its SIC code 2834.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Where is Petros Pharmaceuticals, Inc. headquartered?
Petros Pharmaceuticals, Inc. is headquartered in New York, NY.
What is the SEC file number for Petros Pharmaceuticals?
The SEC file number for Petros Pharmaceuticals is 001-39752.
What is the Central Index Key (CIK) for Petros Pharmaceuticals?
The Central Index Key (CIK) for Petros Pharmaceuticals is 0001815903.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Petros Pharmaceuticals, Inc. (PTPI).